Report Overview

According to the deep-dive market assessment study conducted by Growth+ Reports, the Global Mammography Equipment Marketwas pegged at US$ 2.10 billion in 2021; the market is expected to witness a CAGR of 9.7% from 2022 to 2030.

Market Fundamentals

Mammography is a specialized imaging technique which uses a low dose of x-ray to examine breasts. Mammography exam, also called as mammogram this helps in the early detection and diagnosis of breast related diseases. Mammography works on several methods such as breast tomosynthesis, digital mammography, and computer assisted detection. It can aid in the early detection of cancer in the patients before occurrence of any symptoms. 

[43753423]

Market Dynamics

The increasing prevalence of breast cancer and the rising demand for the early detection of the cancer before occurrence of any symptoms is the key driving factor of the global mammography equipment market. Moreover, the growing government initiatives for the screening and early detection of breast cancer is also playing a pivotal role in the market growth. The increased adoption of advanced technologies, such as AI and computer-aided detection (CAD) with continuous innovation by the key players and the increased access to the screening methods are some of the factors which are propelling the global mammography equipment market. However, the high equipment cost is restricting the growth of the global mammography equipment market. Moreover, there are risks of false negative results, false positive results, radiation exposure and overdiagnosis. The overdiagnosis also leads to overtreatment. According to the American Cancer Society, the percentage of overdiagnoses by mammography is estimated in a range of 1% to 10%.

Market Ecosystem

The global mammography equipment market has been analyzed from four perspectives: product, technology, end user, and region.

Mammography Equipment Market by Product 

[132324]

Based on product, the global mammography equipment market has been segmented into analog systems, breast tomosynthesis system, and full field digital mammography system (FFDM). The full field digital mammography system (FFDM) holds the largest share of the global mammography equipment market in 2021. The dominance of this segment can be attributed to the different advantages of digital mammography over film mammography, which includes lower average radiation dose without a compromise in diagnostic accuracy, retrieval and storage, transmission, and improved ease of image access. Moreover, the FFDM is better able to detect true masses, thus it can overcome the numbers of true positive results and increased the detection of cancers, especially in the breasts with dense parenchyma. 

Mammography Equipment Market by Technology

Based on technology, the global mammography equipment market has been segmented into screen film, 2D mammography, and 3D mammography. At present, the 2D mammography holds the largest share of the global mammography equipment market in 2021. The 3D mammography has the fastest growth rate in this segment. The dominance of 2D mammography can be attributed to the factors such as the cost of 2D mammography is lower compared to other technologies. It is also covered by health insurances. Moreover, most of the breast cancer screening is done before any symptom, thus 2D mammography remain the standard technology and it give equivalent information of most cancers in large number of women. 

Mammography Equipment Market by End User

Based on end user, the global mammography equipment market has been segmented into hospitals, ambulatory centers, and diagnostic centers. Among these, the hospitals segment dominates the global mammography equipment market in 2021.  The large share of the hospitals is attributed to the high patient preference to hospitals thereby resulting in high patient footfall. In addition to having more modern technologies and a considerably larger and more experienced staff, hospitals are also better equipped to process insurance.

Mammography Equipment Market by Region

Based on region, the global mammography equipment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global mammography equipment market in 2021, followed by Europe. Asia Pacific is the fastest growing regional market. The large share of North America in the global market can largely be attributed to the rising prevalence of breast cancer, according to the Centers for Disease Control and Prevention (CDC), around 264,000 case of breast cancer are diagnosed in women and 2,400 in men every year in the U.S., in which about 42,000 women and 500 men die every year. Moreover, the government and non-government organizations are providing breast cancer education and free mammograms for the low-income, uninsured, and underserved women, thus increasing the demand for mammography equipment. The presence of several major players and well-developed healthcare infrastructure is also playing a pivotal rale in the growth of the global mammography equipment market.

Competitive Landscape

The prominent players operating in the global mammography equipment market are:

• Hologic Inc.
• Analogic Corporation
• Canon Medical Systems Corporation
• GE Healthcare
• Siemens Healthcare AG
• Fujifilm Holdings Corporation
• Metaltronica SpA
•  Koninklijke Philips NV
• PLANMED OY
• Delphinus Medical Technologies Inc.

Strategic Development

• In May 2022, RadNet Inc. got clearance from FDA for its subsidiary DeepHealth product called Saige-Dx, an AI based mammography diagnostic software. It identifies suspicious lesions in mammograms and assigns a suspicion level to each case. This AI tool specifically helps in detecting and diagnose of breast cancer and reduces unnecessary recalls. 
• In November 2021, Siemens Healthineers received approval from the FDA for its two new mammography reading and workflow optimization solutions. The Mammovista B.smart reading platform accelerates the reading workflow for breast imaging, and the Teamplay Mammo Dashboard tool optimize workflow through visualization of key performance indicators in breast imaging process.
• In October 2021, Delphinus Medical Technologies received pre-market approval from the FDA for it SoftVueTM 3D Whole Breast Ultrasound Tomography System, which can be used as adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue.

Frequently Asked Questions About This Report